We report changes in CSF and serum neuron-specific enolase (NSE) before and after methohexital infusion during electrocorticography in three patients undergoing epilepsy surgery. NSE is a critical enzyme for energy metabolism that accounts for 1.5% of all soluble brain protein and is an accepted marker of neuronal injury. CSF NSE rose three- to fourfold from baseline within 60 minutes after methohexital activation. Serum NSE was unchanged. This report supports evidence that CSF NSE rises acutely after induction of epileptiform activity and suggests that CSF NSE is a marker of seizure activity.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1212/wnl.44.6.1167 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Association between cerebrospinal fluid levels of neuro-specific enolase after hypothermia alone and in combination with neurodevelopmental outcomes at age six years.
Early Hum Dev
January 2025
Division of Neonatology, Department of Maternal, Fetus and Perinatal Center, Saitama Children's Medical Center, Saitama, Japan.
Background: Hypoxic-ischemic encephalopathy (HIE) is still associated with death and sequelae including cerebral palsy and intellectual disability despite induced hypothermia. Biomarkers, as early predictive indicators of adverse outcomes, are lacking.
Aims: To investigate whether post-rewarming cerebrospinal fluid (CSF)-neuro-specific enolase (NSE) levels after hypothermia are associated with neurodevelopmental outcomes at age six years, alone or when combined with amplitude-integrated electroencephalography (aEEG) and brain magnetic resonance imaging (MRI), as neuroimaging and neurophysiological indicators, respectively.
Cerebrospinal Fluid and Serum Neuron-Specific Enolase in Niemann-Pick Disease Type C1.
Am J Med Genet A
December 2024
Division of Translational Medicine, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institutes of Health, Bethesda, Maryland, USA.
Niemann-Pick disease, type C1 (NPC1) is an ultra rare, autosomal recessive disorder characterized by impaired intracellular cholesterol trafficking. This study assessed neuron-specific enolase (NSE) as a biomarker for disease status and treatment response in individuals with NPC1. We also evaluated the concordance between serum and cerebrospinal fluid (CSF) NSE measurements.
View Article and Find Full Text PDFOn the utility of cerebrospinal fluid biomarkers in canine neurological disorders.
Sci Rep
October 2024
Institute of Neuroimmunology, Slovak Academy of Sciences, Dúbravská Cesta 9, Bratislava, Slovak Republic.
Article Synopsis
- The study investigated whether certain cerebral biomarkers (NfL, amyloid-β, tau, NSE) can help diagnose common canine neurological diseases.
- Elevated levels of tau, NfL, and NSE were found in dogs with meningoencephalitis (MUO), while dogs with brain tumors showed an increase in tau and NSE but a decrease in amyloid-β.
- No significant changes in these biomarkers were found in dogs with non-infectious myelopathies, suggesting that NfL, tau, and NSE might be valuable indicators for MUO and brain tumors in dogs.
Neurosymptomatic HIV-1 CSF escape is associated with replication in CNS T cells and inflammation.
J Clin Invest
October 2024
Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
During antiretroviral therapy (ART), most people living with HIV-1 have undetectable HIV-1 RNA in their plasma. However, they occasionally present with new or progressive neurologic deficits and detectable HIV-1 RNA in the cerebrospinal fluid (CSF), a condition defined as neurosymptomatic HIV-1 CSF escape (NSE). We explored the source of neuropathogenesis and HIV-1 RNA in the CSF during NSE by characterizing HIV-1 populations and inflammatory biomarkers in CSF from 25 individuals with NSE.
View Article and Find Full Text PDFChanges in cerebrospinal fluid proteins across the spectrum of untreated and treated chronic HIV-1 infection.
PLoS Pathog
September 2024
Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Article Synopsis
- Researchers used the Olink Explore 1536 platform to analyze 1,463 unique proteins in cerebrospinal fluid (CSF) from 303 samples, including uninfected controls and various groups of individuals with HIV-1 infection.
- The study found significant correlations between CSF proteins and HIV-1 RNA levels, as well as nerve damage markers, highlighting distinct patterns of protein changes associated with different stages of HIV-1 progression.
- Antiretroviral therapy was shown to lessen protein imbalances in the CSF, although levels didn’t always return to those of uninfected controls; a comprehensive dataset is available online for further research on HIV-1's effects on the CNS.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!